Dongkwang Pharmaceutical is a South Korean pharmaceutical company with decades of experience in pharmaceutical research, development and manufacturing. Founded in 1952, the company has developed a broad portfolio covering prescription medicines, injectable products, topical preparations and other pharmaceutical forms.
For international consumers, one of the company’s recognizable topical products is Silkron Cream. Understanding the company behind the product provides useful context about its origin, manufacturing background and place within Dongkwang Pharmaceutical’s wider portfolio.
In This Article
About Dongkwang Pharmaceutical
Dongkwang Pharmaceutical Co., Ltd. is a pharmaceutical manufacturer headquartered in Seoul, South Korea. The company was established in 1952 and has built its business around pharmaceutical development, manufacturing and distribution.
Over the decades, Dongkwang has expanded from its domestic operations into international markets while developing a diversified range of pharmaceutical products.
The company’s headquarters is located at 97 Toegye-ro, Jung-gu, Seoul, while its manufacturing facility is located in Pyeongtaek, Gyeonggi Province. Dongkwang also operates a central research facility in Seoul.
Dongkwang Pharmaceutical, the South Korean pharmaceutical company that manufactures Silkron Cream.
History and Development
Dongkwang Pharmaceutical traces its modern corporate history to September 1952, when the pharmaceutical company was established in South Korea.
Its development over the following decades included the establishment and relocation of research operations, expansion of pharmaceutical manufacturing capabilities and the construction of its Pyeongtaek production facility.
A major period of expansion occurred during the early 1990s. Dongkwang increased its focus on hospital pharmaceutical products, including injectable medicines, anti-inflammatory products and antibiotics. Construction of the Pyeongtaek factory began in 1991, and the facility was subsequently relocated and expanded as part of the company’s manufacturing development.
In the mid-1990s, Dongkwang also began expanding into overseas markets. Its international activities have since included pharmaceutical exports to multiple regions.
Research and Development
Research and development remains an important part of Dongkwang Pharmaceutical’s long-term strategy.
The company’s stated R&D direction includes pharmaceutical formulation technology, development of differentiated products, advanced manufacturing processes, injectable medicines and research into both synthetic and biological pharmaceutical products.
Dongkwang’s research strategy also includes work on generic medicines, more technically demanding formulations, improved pharmaceutical products and new technology platforms.
The company’s central research facility is located in the Gasan area of Seoul, providing a dedicated base for pharmaceutical research and product development.
Manufacturing Facilities
Dongkwang Pharmaceutical operates a manufacturing facility in Pyeongtaek, Gyeonggi Province, South Korea. The factory forms an important part of the company’s pharmaceutical production infrastructure.
Over its history, the company has developed manufacturing capabilities across multiple dosage forms. These include oral medicines, injectable products and topical pharmaceutical preparations such as creams, ointments and gels.
This diversified manufacturing capability allows Dongkwang to maintain a portfolio spanning numerous pharmaceutical categories rather than concentrating on a single type of medicine.
Dongkwang’s Pharmaceutical Portfolio
Dongkwang Pharmaceutical produces medicines across a wide range of therapeutic and dosage-form categories.
Its broader manufacturing portfolio includes oral solid preparations such as tablets and capsules, injectable medicines, topical creams and ointments, liquid preparations and other pharmaceutical formulations.
The company’s official product information covers therapeutic categories including anti-inflammatory and analgesic medicines, anti-infectives, corticosteroids, antihistamines, dermatological products, cardiovascular medicines, respiratory products and several other areas.
Among the products presented by Dongkwang on its official international website is Silkron Cream, alongside other pharmaceutical products such as Ambroxol injection, Endix-G Cream, Dextasone injection and Triamcinolone injection.
Dongkwang and Silkron Cream
Silkron Medicated Cream is a topical pharmaceutical product manufactured by Dongkwang Pharmaceutical in South Korea.
Silkron is supplied as a 10 g topical cream and contains three active ingredients: betamethasone dipropionate, clotrimazole and gentamicin. These represent a corticosteroid, an antifungal medicine and an antibiotic respectively.
Each 10 g tube lists betamethasone dipropionate 6.4 mg, clotrimazole 100 mg and gentamicin sulfate equivalent to gentamicin 10 mg.
You can also read our Silkron active ingredients guide for a clearer explanation of the formulation.
The presence of Silkron on Dongkwang Pharmaceutical’s official international product website provides direct manufacturer-level confirmation of the connection between the Silkron brand and Dongkwang Pharmaceutical.
Important: Silkron is a medicated topical product. Product information should not be used as a substitute for medical advice. Always follow the original package information and the advice of an appropriately qualified healthcare professional.
International Development
Dongkwang Pharmaceutical’s development has extended beyond the South Korean market. The company began expanding its pharmaceutical exports during the 1990s and subsequently entered markets in different parts of Asia and other regions.
This international development has complemented the company’s domestic pharmaceutical manufacturing and R&D activities and reflects its broader ambition to participate in the global pharmaceutical industry.
Dongkwang’s continuing investment in pharmaceutical research, specialized products and manufacturing technology also supports this international orientation.
Dongkwang Pharmaceutical at a Glance
| Company | Dongkwang Pharmaceutical Co., Ltd. |
|---|---|
| Founded | 1952 |
| Country | South Korea |
| Headquarters | 97 Toegye-ro, Jung-gu, Seoul, South Korea |
| Manufacturing Facility | Pyeongtaek, Gyeonggi Province, South Korea |
| Central Research Facility | Seoul, South Korea |
| Industry | Pharmaceuticals |
| Product Forms | Tablets, capsules, injectable products, creams, ointments, gels and liquid preparations |
| Silkron Manufacturer | Dongkwang Pharmaceutical |
Conclusion
With a history dating back to 1952, Dongkwang Pharmaceutical has developed from a South Korean pharmaceutical manufacturer into a company with research, manufacturing and international operations.
Its activities span pharmaceutical R&D, production of multiple dosage forms and the development of products for both domestic and overseas markets. Silkron Cream is part of this broader pharmaceutical portfolio and is listed among the products presented on Dongkwang Pharmaceutical’s official international website.
For readers researching Silkron, learning about Dongkwang Pharmaceutical provides useful background on the company responsible for manufacturing the product and its place within South Korea’s pharmaceutical industry.
